Zim Laboratories (NSE:ZIMLAB) Other Current Liabilities : ₹185 Mil (As of Mar. 2025)

View and export this data going back to 2022. Start your Free Trial

What is Zim Laboratories Other Current Liabilities?

Zim Laboratories's other current liabilities for the quarter that ended in Mar. 2025 was ₹185 Mil.

Zim Laboratories's quarterly other current liabilities declined from Sep. 2024 (₹221 Mil) to Dec. 2024 (₹0 Mil) but then increased from Dec. 2024 (₹0 Mil) to Mar. 2025 (₹185 Mil).

Zim Laboratories's annual other current liabilities increased from Mar. 2023 (₹109 Mil) to Mar. 2024 (₹157 Mil) and increased from Mar. 2024 (₹157 Mil) to Mar. 2025 (₹185 Mil).

Zim Laboratories Other Current Liabilities Historical Data

The historical data trend for Zim Laboratories's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zim Laboratories Other Current Liabilities Chart

Zim Laboratories Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Other Current Liabilities

Get a 7-Day Free Trial

136.52

280.75

109.46

156.54

185.10

Zim Laboratories Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Current Liabilities	Get a 7-Day Free Trial															156.54	-	221.12	-	185.10

Zim Laboratories Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Zim Laboratories Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Zim Laboratories's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Zim Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zim Laboratories Ltd (NSE:ZIMLAB) » Definitions » Other Current Liabilities

Traded in Other Exchanges

541400:India

Address

Nelson Square, Chhindwara Road, Sadoday Gyan, Ground Floor, Opposite NADT, Nagpur, MH, IND, 440 013

Website

https://www.zimlab.in

Zim Laboratories Ltd is a pharmaceutical company. The company is mainly engaged in the manufacturing of formulation drugs and pre-formulation ingredients. Geographically, the group has a business presence in India and other countries, of which key revenue is derived from Outside India. The products offered by the company are Ondansetron, Melatonin, Nicotine, Vitamin D3, and others. The majority of its revenue is derived from the sale of pharmaceutical goods.

Zim Laboratories Headlines

No Headlines